Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NAPSA Antikörper (AA 20-158)

NAPSA Reaktivität: Human, Ratte WB, ELISA, IHC Wirt: Maus Monoclonal 10C4B8 unconjugated
Produktnummer ABIN1724854
  • Target Alle NAPSA Antikörper anzeigen
    NAPSA (Napsin A Aspartic Peptidase (NAPSA))
    Bindungsspezifität
    • 14
    • 9
    • 8
    • 7
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 20-158
    Reaktivität
    • 77
    • 17
    • 8
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Ratte
    Wirt
    • 52
    • 26
    Maus
    Klonalität
    • 47
    • 31
    Monoklonal
    Konjugat
    • 46
    • 7
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser NAPSA Antikörper ist unkonjugiert
    Applikation
    • 51
    • 30
    • 30
    • 16
    • 15
    • 12
    • 7
    • 7
    • 5
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of human NAPSA (AA: 20-158) expressed in E. coli.
    Klon
    10C4B8
    Isotyp
    IgG1
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified antibody in PBS with 0.05 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Aikawa, Kawahara, Hattori, Yamaguchi, Abe, Taira, Azuma, Kage: "Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings." in: Cancer cytopathology, Vol. 119, Issue 5, pp. 335-45, (2011) (PubMed).

  • Target
    NAPSA (Napsin A Aspartic Peptidase (NAPSA))
    Andere Bezeichnung
    NAPSA (NAPSA Produkte)
    Synonyme
    KAP antikoerper, Kdap antikoerper, NAP1 antikoerper, NAPA antikoerper, SNAPA antikoerper, pronapsin antikoerper, kap antikoerper, kdap antikoerper, nap1 antikoerper, napa antikoerper, napsa antikoerper, snapa antikoerper, napsin A aspartic peptidase antikoerper, napsin A aspartic peptidase L homeolog antikoerper, NAPSA antikoerper, Napsa antikoerper, napsa.L antikoerper
    Hintergrund

    Description: The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. , , ,

    Aliases: KAP, Kdap, NAP1, NAPA, SNAPA

    Molekulargewicht
    45.4 kDa
    Gen-ID
    9476
    HGNC
    9476
    Pathways
    Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Sie sind hier:
Kundenservice